Xavier Montalban Gairín I am director of the Multiple Sclerosis Center of Catalonia (Cemcat) at Vall d'Hebron University Hospital since 2007 and Head of the Neuroimmunology Research Group at Vall d’Hebron Research Institute (VHIR) since 1995. I am Professor of Neurology at the Universitat Autònoma de Barcelona (UAB) since 2006 and at Universitat de Vic – Universitat Central de Catalunya (UVic-UCC) since 2021. Additionally, I serve as Senior Consultant in the Department of Neurology at Vall d'Hebron University Hospital. Institutions of which they are part Head of group Clinical Neuroimmunology Vall Hebron Institut de Recerca Neurology General Hospital Director Multiple Sclerosis Centre of Catalonia LinkedIn Twitter Orcid Email Xavier Montalban Gairín LinkedIn Twitter Orcid Email Institutions of which they are part Head of group Clinical Neuroimmunology Vall Hebron Institut de Recerca Neurology General Hospital Director Multiple Sclerosis Centre of Catalonia I am director of the Multiple Sclerosis Center of Catalonia (Cemcat) at Vall d'Hebron University Hospital since 2007 and Head of the Neuroimmunology Research Group at Vall d’Hebron Research Institute (VHIR) since 1995. I am Professor of Neurology at the Universitat Autònoma de Barcelona (UAB) since 2006 and at Universitat de Vic – Universitat Central de Catalunya (UVic-UCC) since 2021. Additionally, I serve as Senior Consultant in the Department of Neurology at Vall d'Hebron University Hospital.
I obtained my MD (1983) and PhD (1990) from UAB, specializing in Neurology at Vall d'Hebron University Hospital (1988) and completing my postdoctoral fellowship at St Thomas’ Hospital and the National Hospital for Neurology and Neurosurgery (London). I earned a Diploma in Comprehensive Healthcare Institutions Management from ESADE (2005). From 2012 to December 2024, I served as Chair of the Neurology Department at Vall d’Hebron University Hospital. Between 2017 and 2020, I was Professor of Medicine and Director of the Division of Neurology at the University of Toronto, as well as Director of the MS Center at St Michael’s Hospital, Toronto. I am past President (2014-2016) and current Honorary Member of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). I also served as Co-Chair of the Steering Committee of Magnetic Imaging in Multiple Sclerosis (MAGNIMS) and a member of the Steering Committee of the International Progressive MS Alliance. Since December 2024, I have been Vice President of the European Charcot Foundation. Additionally, I chaired the International Advisory Committee on Clinical Trials in MS, sponsored by ECTRIMS and the National Multiple Sclerosis Society (NMSS), until December 2024. My scientific output includes over 800 peer-reviewed publications, with more than 65,000 citations and a Scopus H-Index of 110 (January 2025). Over the last seven years, I have been among Clarivate’s most cited researchers. I have been Principal Investigator (PI) or collaborator in over 35 competitive projects (€8.5 million) and more than 150 clinical trials. Notably, I received the 2022 John Dystel Prize (AAN and NMSS), the 2023 Charcot Award (MSIF) for lifetime achievements in MS research, the 2024 Fundación Lilly Award for Biomedical Research, and the 2023 ICS Career Research Award for clinical and scientific excellence.
Projects UNiC-Unitat de Neuroimmunologia Clínica IP: Xavier Montalban Gairín Collaborators: Carlos Nos Llopis, Jordi Rio Izquierdo, Manuel Comabella Lopez, Mar Tintore Subirana, M Jesus Arevalo Navines, Carmen Espejo Ruiz, Mireia Castillo Juarez Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 35600 Reference: 2005SGR 01081 Duration: 01/01/2006 - 31/12/2008 Investigación en red de las enfermedades neurológicas. IP: Xavier Montalban Gairín Collaborators: Miquel Casas Brugué, Josep Gamez Carbonell, Mario Marotta Baleriola Funding agency: Instituto de Salud Carlos III Funding: 237450 Reference: C03/06 Duration: 01/01/2003 - 31/12/2005 Estudio de la subpoblación de linfocitos T CCR5+ en la etiopatogenia de la esclerosis múltiple (EM) y de la encefalomielitis autoinmune experimental (EAE). IP: Xavier Montalban Gairín Collaborators: Manuel Comabella Lopez, Carmen Espejo Ruiz Funding agency: Instituto de Salud Carlos III Funding: 47150 Reference: PI020160 Duration: 06/11/2002 - 06/11/2005 Immunomodulation in Multiple Sclerosis by Interferon ß. NIH grant application. IP: Xavier Montalban Gairín Collaborators: - Funding agency: National Institutes of Health (NIH) Funding: 1322196 Reference: 1 R01 NS42911 Duration: 01/01/2001 - 31/12/2006 Pagination First page « Previous page ‹ … Page 9 Page 10 Page 11 Current page 12 Page 13 Next page › Last page »
